advanced medical solutions group plc said wednesday that pretax profit rose in 2022 driven by strong sales in both units and that it proposed an increased dividend the uk surgical and woundcare specialist said pretax profit rose to 259 million pounds 315 million in 2022 compared with gbp220 million 2021 on an adjusted basis pretax profit rose to gbp285 million compared with gbp256 million revenue from continuing operations came in at gbp1243 million up from gbp1086 million a year prior driven by commercial progress in both units foreign exchange tailwinds and higher pricing to recover inflationary cost increases the company said sales in both units were strong with surgical revenues increasing by 16 to gbp749 million and woundcare revenues increasing 13 to gbp495 million ams is committed to investing in rd and acquisitions that will further strengthen our established portfolios while continuing to penetrate new markets maintaining robust growth in the longterm chief executive chris meredith said looking ahead the company expects to meet market expectations for 2023 although it sees weak demand in the first half of the year followed by recovery in the second half and much stronger growth thereafter it said based on analyst forecast taken from factset the company is expected to achieve a pretax profit of gbp309 million in 2023 advanced medical solutions proposed an increased final dividend of 151 pence a share up from 137 pence in 2021